IGFBP5 and cancer: Our data also show that, even within the subgroup of ERα-positive breast cancer, cancer cells may or may not respond to MSCs and CAFs by downregulating IGFBP5 expression indicating that ERα-positive breast cancers are a heterogeneous group also in respect to their interactions with stromal cells.